Asian Paints
2596.9 -6.00
Cipla
1493.8 -7.70
Eicher Motors
6727.5 -79.00
Nestle India
1260.5 -5.60
Grasim Inds
2686.1 -14.00
Hindalco Inds.
787.65 -0.75
Hind. Unilever
2414.1 -21.90
ITC
408.6 1.10
Trent
4673 -6.20
Larsen & Toubro
3861.5 -20.10
M & M
3597.3 -21.20
Reliance Industr
1494.1 -2.00
Tata Consumer
1179.5 -10.90
Tata Motors PVeh
405 -2.85
Tata Steel
176.1 -1.17
Wipro
236.74 -3.31
Apollo Hospitals
7682 -100.00
Dr Reddy's Labs
1199.8 -5.40
Titan Company
3752.3 -22.10
SBI
949 -11.75
Shriram Finance
785.9 -6.60
Bharat Electron
407.05 -1.75
Kotak Mah. Bank
2075.4 -7.80
Infosys
1455.2 -11.50
Bajaj Finance
1036 -5.90
Adani Enterp.
2319.1 4.80
Sun Pharma.Inds.
1690.4 4.50
JSW Steel
1156.7 -12.10
HDFC Bank
979.65 -5.00
TCS
2970.4 -40.50
ICICI Bank
1328.8 8.40
Power Grid Corpn
270.55 0.35
Maruti Suzuki
15329 -123.00
Axis Bank
1220.6 -7.90
HCL Technologies
1501.6 -24.80
O N G C
251.7 0.20
NTPC
323.55 -3.10
Coal India
372.95 -0.20
Bharti Airtel
2009 -85.90
Tech Mahindra
1395.8 -17.80
Adani Ports
1434.2 -2.60
HDFC Life Insur.
738.1 2.05
SBI Life Insuran
1975.4 4.60
Max Healthcare
1129 3.60
UltraTech Cem.
11860 -50.00
Bajaj Auto
8624 -96.50
Bajaj Finserv
2047.3 -15.90
Interglobe Aviat
5648.5 -44.50
Eternal Ltd
305 -0.65
Realty shares tumbled for second consecutive trading session.
At 14:25 IST, the barometer index, the S&P BSE Sensex declined 47.59 points or 0.06% to 83,419.87. The Nifty 50 index fell 62.95 points or 0.25% to 25,534.40.
The broader market underperformed the frontline indices. The S&P BSE Mid-Cap index declined 1.33% and the S&P BSE Small-Cap index fell 0.47%.
The market breadth was weak. On the BSE, 1,188 shares rose and 2,960 shares fell. A total of 167 shares were unchanged.
Economy:
The seasonally adjusted HSBC India Services PMI Business Activity Index stood at 58.9 in October, comfortably above both the neutral mark of 50.0 and its long-run average of 54.3. October data showed softer, although still substantial, expansions in Indian services output and new business. While factors like demand buoyancy and GST (Goods and Services Tax) relief reportedly led to an improvement in operating conditions, competition and heavy rains constrained growth.
HSBC India Composite PMI Output Index fell to 60.4 in October from 61.0 in September. There was also a weaker, albeit still substantial, upturn in aggregate sales. The rate of expansion was the softest in five months. For new orders and output, the slowdowns in growth were centred on the service economy as manufacturers actually registered quicker rates of expansion.
Buzzing Index:
The Nifty Realty index fell 1.27% to 948.85. The index dropped 2.04% in the two consecutive trading sessions.
Anant Raj (down 3.49%), Godrej Properties (down 3.45%), Brigade Enterprises (down 2.46%), DLF (down 2.03%), Prestige Estates Projects (down 1.31%), Phoenix Mills (down 1.24%) and Oberoi Realty (down 0.02%) declined.
Numbers to Track:
The yield on India's 10-year benchmark federal paper shed 0.47% to 6.499 from the previous close of 6.530.
In the foreign exchange market, the rupee edged higher against the dollar. The partially convertible rupee was hovering at 88.6400 compared with its close of 88.7700 during the previous trading session.
MCX Gold futures for 5 December 2025 settlement rose 0.71% to Rs 121,376.
The US Dollar Index (DXY), which tracks the greenback's value against a basket of currencies, was down 0.15% to 100.02.
The United States 10-year bond yield fell 0.38% to 4.143.
In the commodities market, Brent crude for December 2025 settlement advanced 34 cents or 0.54% to $63.86 a barrel.
Stocks in Spotlight:
Devyani International (DIL) declined 2.105 after the company reported a mixed Q2 FY26 performance, with net loss widening to Rs 23.95 crore from Rs 4.92 crore in Q2 FY25, despite revenue growth driven by network expansion and steady demand. On a consolidated basis, revenue from operations increased 12.7% year-on-year to Rs 1,376.75 crore in the quarter ended September 2025.
Indoco Remedies fell 1.70%. The company consolidated net loss narrowed to Rs 9.21 crore in Q2 FY26, compared with net loss of Rs 10.01 crore reported in Q2 FY25. Revenue from operations stood at Rs 471.83 crore in the second quarter of FY26, up 9.59% as against Rs 430.66 crore posted in Q2 FY25.
Piramal Pharma rose 0.92%, The company reported a consolidated net loss of Rs 99.22 crore in Q2 FY26, compared with a net profit of Rs 22.59 crore recorded in Q2 FY25. Revenue from operations for the period under review declined 8.83% year-on-year (YoY) to Rs 2,043.72 crore. The YoY performance was impacted by inventory destocking by a customer in one large CDMO order.
Powered by Capital Market - Live News